๐Ÿ‡ฌ๐Ÿ‡ง UK Inflation Hits 3.6%: What It Means for Savers and Tracker Borrowers๐Ÿ‡บ๐Ÿ‡ธ Who Should Refinance at 7.11%? Break-Even by Loan Vintage๐Ÿ‡บ๐Ÿ‡ธ Binance's $6.3bn Hack Shows How Little Crypto Theft Is Insured๐Ÿ‡ฆ๐Ÿ‡บ Australian Home Cover Rises 6% as Rates Hit 4.85%: The Squeeze๐Ÿ‡บ๐Ÿ‡ธ Cowbell Launches Standalone Insurance for Damage Done by AI Agents๐Ÿ‡ฎ๐Ÿ‡ณ IRDAI Starts Work on Risk-Based Capital Rules for Indian Insurers๐Ÿ‡บ๐Ÿ‡ธ Microsoft 365 Outage: Why Most of the Loss Will Stay Uninsured๐Ÿ‡ธ๐Ÿ‡ฌ Asia Insurance Prices Fall Again, but Not for Japan or Motor Cover๐Ÿ‡บ๐Ÿ‡ธ When Insurers Leave, Home Values Fall: What Cotality's Data Shows๐Ÿ‡ซ๐Ÿ‡ท MAIF Launches In-House Reinsurer With EUR 145m of Capital๐Ÿ‡ฌ๐Ÿ‡ง UK Inflation Hits 3.6%: What It Means for Savers and Tracker Borrowers๐Ÿ‡บ๐Ÿ‡ธ Who Should Refinance at 7.11%? Break-Even by Loan Vintage๐Ÿ‡บ๐Ÿ‡ธ Binance's $6.3bn Hack Shows How Little Crypto Theft Is Insured๐Ÿ‡ฆ๐Ÿ‡บ Australian Home Cover Rises 6% as Rates Hit 4.85%: The Squeeze๐Ÿ‡บ๐Ÿ‡ธ Cowbell Launches Standalone Insurance for Damage Done by AI Agents๐Ÿ‡ฎ๐Ÿ‡ณ IRDAI Starts Work on Risk-Based Capital Rules for Indian Insurers๐Ÿ‡บ๐Ÿ‡ธ Microsoft 365 Outage: Why Most of the Loss Will Stay Uninsured๐Ÿ‡ธ๐Ÿ‡ฌ Asia Insurance Prices Fall Again, but Not for Japan or Motor Cover๐Ÿ‡บ๐Ÿ‡ธ When Insurers Leave, Home Values Fall: What Cotality's Data Shows๐Ÿ‡ซ๐Ÿ‡ท MAIF Launches In-House Reinsurer With EUR 145m of Capital
Doctor speaking with an older patient representing Medicare coverage decisions (illustrative)
Healthcare Insurance๐Ÿ‡บ๐Ÿ‡ธUnited States

Medicare 2027: Which Costs Are Final and Which Are Still Estimates

PolicyRix Teamยทยท7 min read
ShareXLinkedInWhatsApp
Verified Story

With Medicare open enrollment ending December 7, a PolicyRix Team breakdown shows the Part D cap rises to $2,400 and the deductible to $700 for 2027, while the $209.50 Part B premium is still a Trustees projection, and a high drug user could pay about $416 more in total.

Medicare open enrollment runs until December 7, and people choosing a plan for 2027 are working with a mix of firm numbers and estimates. Some 2027 costs were finalised months ago. Others, including the standard Part B premium that most beneficiaries pay, had not been published by the Centers for Medicare and Medicaid Services in the sources we checked when this was written, and are still based on the projection in the 2026 Medicare Trustees Report. Knowing which is which matters, because plan choices are locked in for the year.

This PolicyRix Team explainer sets out what is final, what is projected, and what the changes add up to for an example beneficiary. The figures come from published CMS amounts and the Trustees Report as reported by several Medicare information sites; the totals are our own calculations.

What is already final for 2027

The Part D prescription drug figures are set. The standard Part D deductible rises to $700 from $615, an increase of about 14%. The annual out-of-pocket cap on covered drug costs rises to $2,400 from $2,100, an increase of $300, or about 14%. CMS also set the national base beneficiary premium, a benchmark used in calculating Part D premiums and late enrollment penalties, at $41.33 a month, up about 6% from $38.99. The base premium is not what any particular plan charges; each plan sets its own premium.

What is still a projection

The 2026 Trustees Report estimated the 2027 standard Part B premium at $209.50 a month, up $6.60, or about 3.3%, from $202.90 in 2026. It projected the Part B deductible at $292, up $9 from $283. The Part A hospital deductible and the income brackets for higher-income surcharges, known as IRMAA, are also announced with the Part B premium. CMS released the 2026 figures on November 14, 2025, and the 2025 figures on November 8, 2024, so the official 2027 numbers are due around now. Some private forecasts have suggested a higher premium, so the Trustees figure is a reasonable planning number rather than a certainty.

Separately, the administration announced in October a one-time $90 payment to about 20.8 million original Medicare beneficiaries to help with Part B premiums, according to AARP. On the projected 2027 premium, $90 would cover about 43% of one month.

Worked example: a beneficiary with high drug costs

Consider someone in original Medicare with a stand-alone Part D plan whose drug costs are high enough to reach the out-of-pocket cap. Using the national base premium as a stand-in for the plan premium, which is a simplification, our calculation of the main annual costs is:

2026: Part B premium of $2,434.80, Part B deductible of $283, Part D cap of $2,100 and base Part D premium of $467.88, a total of about $5,286.

2027: Part B premium of $2,514 at the projected rate, Part B deductible of $292, Part D cap of $2,400 and base Part D premium of $495.96, a total of about $5,702.

That is an increase of about $416, or roughly 8%, and most of it comes from the higher drug cap. For someone with low drug costs who never reaches the Part D deductible, the change is much smaller and comes mainly from the Part B premium, which on the projection rises by about $79 for the year.

What it means for people choosing a plan

The rise in the drug cap is the change most likely to affect heavy medication users, and it is already certain. People who expect to hit the cap should compare plans on total yearly cost, using Medicare's plan finder with their actual drug list, rather than on monthly premium alone. A plan with a higher premium can be cheaper overall if it covers a key drug at a lower tier. People with Medicare Advantage should check whether their plan's drug coverage, network or extra benefits changed for 2027, since plans can change each year. Anyone whose income was high in 2025 should watch for the IRMAA brackets, because the 2027 surcharge is based on the 2025 tax return.

What the data cannot tell us

The Part B premium and deductible in our example are projections and may change when CMS publishes the official amounts. Actual Part D premiums vary by plan and region, and many beneficiaries receive help through Extra Help or employer coverage. The example ignores Part B coinsurance, which is 20% of approved costs after the deductible and can be large, as well as supplemental Medigap premiums. Social Security cost-of-living adjustments also offset part of the increase for many people.

The firm takeaway is that drug costs at the top end are going up by $300 next year regardless of the Part B announcement, and open enrollment is the window to choose a plan with that in mind.

Key Points

  • 1Final for 2027: the Part D deductible rises to $700 from $615 and the out-of-pocket drug cap to $2,400 from $2,100, while the national base beneficiary premium is $41.33.
  • 2Still projected: the Trustees Report puts the standard Part B premium at $209.50 a month, up $6.60, and the Part B deductible at $292.
  • 3CMS published 2026 amounts on November 14, 2025, so the official 2027 Part B figures are due around now.
  • 4On our example, a beneficiary who hits the drug cap faces about $5,702 of main costs in 2027 against about $5,286 in 2026, an increase of about $416.
  • 5Open enrollment ends December 7; heavy drug users should compare total yearly cost, not premium alone.

Why This Matters

Medicare plan choices are locked in for a year, and open enrollment closes on December 7. Separating confirmed 2027 costs from estimates helps beneficiaries budget correctly and pick a plan on total cost, especially those with high drug bills facing a $300 higher cap.

#medicare#open enrollment#part b premium#part d#2027#healthcare insurance#explainer
Disclaimer: This article is for informational purposes only and does not constitute financial, investment, legal, or insurance advice. Always consult a qualified professional before making financial decisions. PolicyRix reports on publicly available information from third-party sources and cannot guarantee the accuracy or completeness of such information.

Related Stories

Daily Intelligence

The PolicyRix Daily Brief

Get the day's key insurance and finance stories in one email, each linked to its original source. No spam. Unsubscribe anytime.

Informational newsletter only. Not financial advice. Disclaimer